NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,001,000 | -58.3% | 24,609 | -4.2% | 0.01% | -54.2% |
Q4 2021 | $2,398,000 | -17.0% | 25,678 | -0.9% | 0.02% | -17.2% |
Q3 2021 | $2,888,000 | -3.2% | 25,918 | -1.4% | 0.03% | 0.0% |
Q2 2021 | $2,985,000 | -49.7% | 26,292 | -55.0% | 0.03% | -53.2% |
Q1 2021 | $5,934,000 | -3.3% | 58,437 | -5.2% | 0.06% | -11.4% |
Q4 2020 | $6,137,000 | +34.7% | 61,663 | -2.2% | 0.07% | +14.8% |
Q3 2020 | $4,555,000 | +23.7% | 63,049 | -14.6% | 0.06% | +17.3% |
Q2 2020 | $3,681,000 | +56.4% | 73,836 | -6.3% | 0.05% | +33.3% |
Q1 2020 | $2,354,000 | -15.1% | 78,831 | -4.2% | 0.04% | +11.4% |
Q4 2019 | $2,773,000 | +89.9% | 82,296 | +84.9% | 0.04% | +75.0% |
Q3 2019 | $1,460,000 | – | 44,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |